Evaluating opioid use after surgery in genitourinary cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the amount of opioids consumed by patients after discharge following surgeries for genitourinary cancers, including cystectomies, nephrectomies, and prostatectomies. Participants will complete a 30-day survey to evaluate their opioid usage and disposal habits, as well as their satisfaction with surgical care. Additionally, an educational pamphlet on proper opioid disposal will be provided to participants starting in the second year of the study. The goal is to understand post-operative opioid consumption and improve disposal practices.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Written informed consent and HIPAA authorization for release of personal health information.
2. Age ≥ 18 years at the time of enrollment
3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
4. Ability to read and understand the English and/or Spanish language.
5. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.

Exclusion Criteria:

* None

Where it's running

• Levine Cancer Institute
  Charlotte, North Carolina, United States Recruiting

Study contacts

• Principal investigator: Stephen Riggs, MD — Wake Forest University Health Sciences
• Study coordinator: Margarita Dzhanumova
• Email: Margarita.Dzhanumova@advocatehealth.org
• Phone: 704-355-2000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)

  This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07524114

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

• High-resolution imaging to check if tumors are completely removed during surgery

  This study is testing if high-resolution imaging during surgery can help make sure all tumors are removed in patients with different types of cancer, like breast, prostate, and thyroid, to improve their treatment outcomes.

  Recruiting Algemeen Ziekenhuis Maria Middelares · Ghent, Oost Vlaanderen · NCT06835426

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

• Understanding Urothelial and Rare Genitourinary Cancers

  This study is trying to learn more about urothelial and rare genitourinary cancers by gathering health information and samples from adults who have been diagnosed with these cancers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT04923178

• Using blood tests to assess early treatment response in cancer patients

  This study is testing if blood tests that look for cancer DNA can help doctors see how well treatment is working for patients with different types of solid tumors.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT04354064

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.